| Name | Title | Contact Details |
|---|
TearLab Corporation develops and commercializes lab-on-a-chip technologies that enable eye care practitioners to improve standard of care by quantitatively testing for disease markers in tears at the point-of-care. Headquartered in San Diego, CA, TearLab Corporation`s common shares trade on the NASDAQ Capital Market under the symbol `TEAR` and on the Toronto Stock Exchange under the symbol `TLB`. Dry Eye Disease (DED) is a chronic, progressive disease. Morgan Stanley’s Dry Eye Market Report (2003) estimates that 30 to 60 million Americans suffer from dry eye symptoms. Only 10 million are diagnosed with the disease. Millions more suffer worldwide. The TearLab™ Osmolarity System provides the first quantitative and objective diagnostic technology that allows doctors to effectively manage their dry eye patients. TearLab will allow practitioners to diagnosis DED patients early in the disease process allowing for early intervention. TearLab received the CE Mark for its TearLab Osmolarity System in 2008 and FDA Clearance in 2009. TearLab is currently marketed globally in more than 14 countries including the US.
Metamason is dedicated to improving healthcare through technological innovation. Our health-focused software platform uses 3D scans of the body to create individually customized, 3D-printed products engineered for flawless fit.
Medcare Products is a Burnsville, MN-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
"SensiVida Medical Technologies, Inc. is a minimally invasive Diagnostic Device company. Our patented Microsystems-based optical technology automates bio-sensing and data acquisition while minimizing patient discomfort. Our ""platform"" technology can be applied to a number of disease state diagnostics, including allergy testing, pain-free automated glucose monitoring and blood coagulation testing (e.g. for Coumadin patients), TB testing, and cholesterol monitoring."
Vertiflex is committed to delivering clinically proven treatments for lumbar stenosis that are minimally invasive in order to help people take back their lives.